A Phase 1/2, Multicenter, Open-label Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Body, Amy (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA HREC Reference Number: 91742
NMA SSA Reference Number: SSA/91742/MonH-2023-362708(v1)
Monash Health Local Reference: RES-22-0000-717A

Status	Active
Effective start/end date	3/05/23 → 2/05/28

Clinical Trial Phase

Phase I
Phase II